Reset filter
Trefwoorden
ALL ×
Meer tonen Trefwoorden
Inhoudsopgave
  1. 1. Klinische studie
  2. 2. Routinedocumentatie
  3. 3. Register-/kohortstudies
  4. 4. Kwaliteitswaarborging
  5. 5. Datastandaard
  6. 6. Patiëntenvragenlijst
  7. 7. Medisch vakgebied
Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

113 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Eligibility Leukemia NCT00129558

- 18-04-17 - 1 Formulier, 2 Itemgroepen, 11 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
A Study to Evaluate PT-523 in Patients With Refractory Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00129558

Biobank MS University Hospital Muenster (UKM)

- 17-10-16 - 1 Formulier, 2 Itemgroepen, 16 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Material testing
Hospital Routine Documentation Form at the University Hospital Muenster. Original Form name: Biobank MS.

Eligibility Leukemia NCT00458848

- 07-10-16 - 1 Formulier, 1 Itemgroep, 16 Data-elementen, 1 Taal
Itemgroep: Criteria
Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00458848

Eligibility Leukemia NCT00343369

- 06-10-16 - 1 Formulier, 1 Itemgroep, 15 Data-elementen, 1 Taal
Itemgroep: Criteria
Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00343369

Eligibility Leukemia NCT00075725

- 05-10-16 - 1 Formulier, 1 Itemgroep, 28 Data-elementen, 1 Taal
Itemgroep: Criteria
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00075725

Eligibility L1 Childhood Acute Lymphoblastic Leukemia NCT00049569

- 04-10-16 - 1 Formulier, 2 Itemgroepen, 14 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00049569

Protocol medication AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol medication AIEOP-BFM ALL 2009 NCT01117441

- 14-07-16 - 1 Formulier, 14 Itemgroepen, 57 Data-elementen, 1 Taal
Itemgroepen: Patient Information, First Element, Second Element, Third Element, Fourth Element, Fifth Element, Sixth Element, Seventh Element, Eighth Element, Ninth Element, Cranial radiation, Maintenance treatment, Comments, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Documentation of administered protocol medication Clinical Trial Number: NCT01117441.

Eligibility Lymphoblastic Leukemia, Acute NCT00131027

- 11-06-16 - 1 Formulier, 2 Itemgroepen, 11 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT00131027

Documentation of therapy toxicity AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Documentation of therapy toxicity AIEOP-BFM ALL 2009 NCT01117441

- 31-05-16 - 1 Formulier, 6 Itemgroepen, 25 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Therapy, Blood analysis, Toxicity, Comments, Identification and Signature
Study Description Stamm: International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Documentation of therapy toxicity. Clinical Trial Number: NCT01117441.

Eligibility Drug/Agent Toxicity by Tissue/Organ NCT00055718

- 29-05-16 - 1 Formulier, 4 Itemgroepen, 18 Data-elementen, 1 Taal
Itemgroepen: Criteria, Patient Caracteristics, Disease Caracteristics, Prior concurrent therapy
Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT00055718

Protocol IIIA AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IIIA AIEOP-BFM ALL 2009 NCT01117441

- 21-05-16 - 1 Formulier, 4 Itemgroepen, 32 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IIIA. Clinical Trial Number: NCT01117441.

Protocol IIB-ASP+ AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IIB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

- 21-05-16 - 1 Formulier, 5 Itemgroepen, 28 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Chemotherapy Regimen, PEG-L-ASP discontinuation, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IIB (Study Protocol IIB with PEG-L-ASP). Clinical Trial Number: NCT01117441.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial